
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
TrialScope has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch a new website. The site is designed to educate and inform about the clinical trial journey, as well as provide specific information about clinical trials conducted by Merck KGaA, Darmstadt, Germany, and its affiliates.
For more information, click






